In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.11.22.21266681
Publication URI: http://dx.doi.org/10.1101/2021.11.22.21266681
Type: Preprint